Strategies for an Innovative Drug Maker to Retain its First-Mover Advantage when faced with Patent Expiry and impending Generic Competition
An innovative pharmaceutical company is known to enjoy a First-Mover Advantage when it launches a patented drug in the market. However, research suggests that the edge diminishes with time. With a major patent cliff round the corner, originators are in dire need of some way to retain their once acqu...
| Main Author: | |
|---|---|
| Format: | Dissertation (University of Nottingham only) |
| Language: | English |
| Published: |
2011
|
| Online Access: | https://eprints.nottingham.ac.uk/24839/ |